Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-09-06 Purchase | 2022-09-08 6:51 pm | CASI Pharmaceuticals Inc. | CASI | Huang James Director | 55,573 | $4.1326 | $229,662 | 371,708 (Indirect Direct) | View |
| 2022-08-31 Purchase | 2022-09-02 7:35 pm | CASI Pharmaceuticals Inc. | CASI | Huang James Director | 37,196 | $3.7379 | $139,036 | 316,135 (Indirect Direct) | View |
| 2022-08-24 Purchase | 2022-08-26 8:48 pm | CASI Pharmaceuticals Inc. | CASI | Huang James Director | 44,527 | $3.749 | $166,930 | 278,939 (Indirect Direct) | View |
| 2022-08-19 Purchase | 2022-08-23 8:19 pm | CASI Pharmaceuticals Inc. | CASI | Huang James Director | 234,221 | $3.328 | $779,477 | 234,412 (Indirect Direct) | View |
| 2022-06-13 Purchase | 2022-06-17 4:14 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner | 88,154 | $3.0912 | $272,506 | 1,741,894 (Indirect Direct) | View |
| 2021-11-17 Purchase | 2021-11-19 4:10 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO | 400,000 | $0.985 | $394,000 | 16,531,891 (Indirect Direct) | View |
| 2021-08-18 Purchase | 2021-08-20 4:27 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO | 480,000 | $1.2788 | $613,800 | 16,137,413 (Indirect Direct) | View |
| 2021-03-26 Purchase | 2021-03-30 4:52 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO | 3,000,000 | $2.05 | $6,150,000 | 15,657,413 (Indirect Direct) | View |
| 2020-12-16 Purchase | 2020-12-18 4:05 pm | CASI Pharmaceuticals Inc. | CASI | Xu Weihao Chief Financial Officer | 6,000 | $2.5695 | $15,417 | 810,000 (Indirect Direct) | View |
| 2020-11-20 Purchase | 2020-11-24 5:39 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO | 227,471 | $2.1464 | $488,239 | 13,037,413 (Indirect Direct) | View |
| 2020-07-22 Purchase | 2020-07-24 4:05 pm | CASI Pharmaceuticals Inc. | CASI | Zhang Larry President | 20,153 | $1.9 | $38,291 | 20,153 (Direct) | View |
| 2020-07-22 Purchase | 2020-07-24 4:03 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner | 4,152,426 | $1.9 | $7,889,609 | 12,809,942 (Indirect Direct) | View |
| 2020-05-19 Purchase | 2020-05-21 5:01 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner | 86,265 | $2.2525 | $194,316 | 8,657,516 (Indirect Direct) | View |
| 2020-05-15 Purchase | 2020-05-19 5:55 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner | 438,932 | $1.9744 | $866,643 | 8,571,251 (Indirect Direct) | View |
| 2020-03-27 Purchase | 2020-03-30 4:01 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO | 6,880 | $2.08 | $14,310 | 8,132,319 (Indirect Direct) | View |
| 2020-03-25 Purchase | 2020-03-27 5:07 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner | 524,493 | $2.0338 | $1,066,731 | 8,125,439 (Indirect Direct) | View |
| 2020-03-17 Purchase | 2020-03-19 5:39 pm | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner | 1,000,002 | $1.5264 | $1,526,444 | 7,600,946 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-09-07 Option Award | 2022-09-09 4:01 pm | N/A 2031-05-25 | CASI Pharmaceuticals Inc. | CASI | Zukiwski Alexander A EVP and Chief Medical Officer | 3,000 | $0 | 3,000 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 4:24 pm | N/A 2032-05-25 | CASI Pharmaceuticals Inc. | CASI | Zhou Quan Director | 380,645 | $0 | 380,645 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 4:23 pm | N/A 2032-05-25 | CASI Pharmaceuticals Inc. | CASI | Huang James Director | 397,419 | $0 | 397,419 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 4:13 pm | N/A 2032-05-25 | CASI Pharmaceuticals Inc. | CASI | Wu Yue Alexander Director | 388,387 | $0 | 388,387 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 4:12 pm | N/A 2032-05-25 | CASI Pharmaceuticals Inc. | CASI | Salisbury Franklin Cary jr Director | 388,387 | $0 | 388,387 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 4:11 pm | N/A 2032-05-25 | CASI Pharmaceuticals Inc. | CASI | SHROTRIYA RAJESH C MD Director | 345,806 | $0 | 345,806 (Direct) | View |
| 2021-12-02 Option Award | 2021-12-06 4:12 pm | N/A 2031-12-02 | CASI Pharmaceuticals Inc. | CASI | Zukiwski Alexander A Chief Medical Officer | 500,000 | $0 | 500,000 (Direct) | View |
| 2021-07-24 Option Award | 2021-07-26 6:08 pm | N/A 2031-07-24 | CASI Pharmaceuticals Inc. | CASI | Zhang Larry President | 800,000 | $0 | 800,000 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-16 4:02 pm | N/A 2031-06-15 | CASI Pharmaceuticals Inc. | CASI | Zhou Quan Director | 108,257 | $0 | 108,257 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-16 4:02 pm | N/A 2031-06-15 | CASI Pharmaceuticals Inc. | CASI | Wu Yue Alexander Director | 110,459 | $0 | 110,459 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-16 4:02 pm | N/A 2031-06-15 | CASI Pharmaceuticals Inc. | CASI | SHROTRIYA RAJESH C MD Director | 98 | $0 | 98,349 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-16 4:02 pm | N/A 2031-06-15 | CASI Pharmaceuticals Inc. | CASI | Salisbury Franklin Cary jr Director | 110,459 | $0 | 110,459 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-16 4:01 pm | N/A 2031-06-15 | CASI Pharmaceuticals Inc. | CASI | Huang James Director | 113,028 | $0 | 113,028 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-16 4:01 pm | N/A 2031-04-27 | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner | 4,000,000 | $0 | 4,000,000 (Direct) | View |
| 2020-12-22 Gift | 2020-12-23 4:02 pm | N/A N/A | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO | 380,000 | $0 | 12,657,413 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-18 4:05 pm | N/A 2030-12-16 | CASI Pharmaceuticals Inc. | CASI | Xu Weihao Chief Financial Officer | 800,000 | $0 | 810,000 (Direct) | View |
Ownership | 2020-12-18 4:05 pm | N/A N/A | CASI Pharmaceuticals Inc. | CASI | Xu Weihao Chief Financial Officer | 0 | $0 | 4,000 (Indirect) | View |
| 2020-06-16 Option Award | 2020-06-18 06:07 am | N/A 2030-06-16 | CASI Pharmaceuticals Inc. | CASI | Zhou Quan Director | 67,429 | $0 | 67,429 (Direct) | View |
| 2020-06-16 Option Award | 2020-06-18 06:05 am | N/A 2030-06-16 | CASI Pharmaceuticals Inc. | CASI | Huang James Director | 70,400 | $0 | 70,400 (Direct) | View |
| 2020-06-16 Option Award | 2020-06-18 06:04 am | N/A 2030-06-16 | CASI Pharmaceuticals Inc. | CASI | Wu Yue Alexander Director | 68,800 | $0 | 68,800 (Direct) | View |
| 2020-06-16 Option Award | 2020-06-18 06:03 am | N/A 2030-06-16 | CASI Pharmaceuticals Inc. | CASI | Salisbury Franklin Cary jr Director | 68,800 | $0 | 68,800 (Direct) | View |
| 2020-06-16 Option Award | 2020-06-18 06:02 am | N/A 2030-06-16 | CASI Pharmaceuticals Inc. | CASI | SHROTRIYA RAJESH C MD Director | 61,257 | $0 | 61,257 (Direct) | View |
| 2019-12-30 Exercise | 2020-01-06 4:01 pm | N/A N/A | CASI Pharmaceuticals Inc. | CASI | Wealth Strategy Holding Ltd 10% Owner | 493,827 | $1.69 | 9,087,888 (Direct) | View |
| 2019-12-30 Exercise | 2020-01-06 4:01 pm | 2017-01-23 2020-01-23 | CASI Pharmaceuticals Inc. | CASI | Wealth Strategy Holding Ltd 10% Owner | 493,827 | $0.125 | 9,087,888 (Direct) | View |
| 2019-12-16 Exercise | 2019-12-18 4:01 pm | N/A N/A | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner | 374,321 | $1.69 | 6,600,944 (Indirect) | View |
| 2019-12-16 Exercise | 2019-12-18 4:01 pm | 2017-01-02 2020-01-02 | CASI Pharmaceuticals Inc. | CASI | He Wei-Wu Chairman and CEO 10% Owner | 374,321 | $0 | 6,600,944 (Indirect) | View |